ABCDEFGHIJKLMNOPQRS
1
From
Side
From
Region
To
Side
To
Region
Data
Type
Reported
Value
Report
Selected
Date
Selected
Connectome
Version
Inj. Site
Size
Inj. Site
Extension
Extended
Regions
Axonal
Tracing Method
Male or
Female
CollatorReference
Article
Reference
Weblink
Regional
Nomenclature
Additional
Annotations
2
oneGPmoneIIIanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
3
oneGPmtwoIIIanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
4
oneGPmoneIVanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
5
oneGPmtwoIVanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
6
oneGPmoneMANanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
7
oneGPmtwoMANanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
8
oneGPmoneEWanterov.weakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3f,h; compare with Swanson (2018) AL38, 40.
9
oneGPmtwoEWanterov.weakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3f,h; compare with Swanson (2018) AL38, 40.
10
oneGPmoneNDanteroweak-modyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
11
oneGPmoneNDretroabsentno1mediummediumPAGl, MAN, EWFluoro-GoldmaleSwanson, L.W.da Silva, A.V. et al. (2013) J. Chem. Neuroanat. 54:5-19.https://pubmed.ncbi.nlm.nih.gov/23619059/Author(s) naming schemaInjections too large to use for positive Connection Reports; useful for negative evidence (see Table 1; their DK). For injection sites see Fig. 9D-F; compare with Swanson (2018) AL39-40.
12
oneGPmtwoNDanteroweakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
13
oneGPmtwoNDretroabsentno1mediummediumPAGl, MAN, EWFluoro-GoldmaleSwanson, L.W.da Silva, A.V. et al. (2013) J. Chem. Neuroanat. 54:5-19.https://pubmed.ncbi.nlm.nih.gov/23619059/Author(s) naming schemaInjections too large to use for positive Connection Reports; useful for negative evidence (see Table 1; their DK). For injection sites see Fig. 9D-F; compare with Swanson (2018) AL39-40.
14
oneGPmoneINCanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
15
oneGPmtwoINCanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
16
oneGPmoneMTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
17
oneGPmtwoMTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
18
oneGPmoneLTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
19
oneGPmoneLTretroabsentno1v.largelargePP, SPFp, MRNm, MGm (v. small)WGA-HRPunreportedSwanson, L.W.Arnault, P. & Roger, M. (1987) J. Comp. Neurol. 258:463-476.https://pubmed.ncbi.nlm.nih.gov/3584548/Author(s) naming schemaInjections too large (e.g., Figs. 2, 3; for MB compare with Swanson, 2018, AL38-50) to use for positive evidence; useful for negative evidence (Table 1; pp. 464-469).
20
oneGPmtwoLTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
21
oneGPmtwoLTretroabsentno1v.largelargePP, SPFp, MRNm, MGm (v. small)WGA-HRPunreportedSwanson, L.W.Arnault, P. & Roger, M. (1987) J. Comp. Neurol. 258:463-476.https://pubmed.ncbi.nlm.nih.gov/3584548/Author(s) naming schemaInjections too large (e.g., Figs. 2, 3; for MB compare with Swanson, 2018, AL38-50) to use for positive evidence; useful for negative evidence (Table 1; pp. 464-469).
22
oneGPmoneDTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
23
oneGPmtwoDTanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
24
oneGPmoneRLanteroax.pass.yes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
25
oneGPmtwoRLanteroax.pass.yes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
26
oneGPmoneIFanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
27
oneGPmoneIFretroabsentno1med-largemed-largeIF contralateral, RL (v. small)HRPfemaleSwanson, L.W.Phillipson, O.T. (1979) J. Comp. Neurol. 187:117-144.https://pubmed.ncbi.nlm.nih.gov/489776/Author(s) naming schemaInjection too large to use positive results; useful for negative evidence ("absent" Connection Reports; see Table 1-31). For injection site see Fig. 2-31; compare with Swanson (2018) AL37.
28
oneGPmtwoIFanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
29
oneGPmtwoIFretroabsentno1med-largemed-largeIF contralateral, RL (v. small)HRPfemaleSwanson, L.W.Phillipson, O.T. (1979) J. Comp. Neurol. 187:117-144.https://pubmed.ncbi.nlm.nih.gov/489776/Author(s) naming schemaInjection too large to use positive results; useful for negative evidence ("absent" Connection Reports; see Table 1-31). For injection site see Fig. 2-31; compare with Swanson (2018) AL37.
30
oneGPmoneIPNanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
31
oneGPmoneIPNretroabsentno1v.largev.largeIP contralateral, PON, CS (v. small)Fluoro-GoldmaleSwanson, L.W.Jhou, T.C. et al. (2009) J. Comp. Neurol. 513:566-596.https://pmc.ncbi.nlm.nih.gov/articles/PMC3116663/Paxinos & Watson (1998)Injection too large to use positive results; useful for negative evidence ("absent" Connection Reports; see Table 1-08031). For injection site see Fig. 6-08031; compare with Swanson (2018) AL40-45.
32
oneGPmoneIPNretroabsentno1largelargeIP contralateral, VTA and unspecified (v. small)CTB (retrograde)maleSwanson, L.W.Lima, L.B. et al. (2017) J. Comp. Neurol. 525:2411-2442.https://pubmed.ncbi.nlm.nih.gov/28340505/Paxinos & Watson (2007)Injections too large to use positive results; useful for negative evidence ("absent" Connection Reports; see pp. 2420-2425 & Fig. 8). For injection sites see Fig. 7a-c (different injection sites not distinguished in textual description); compare with Swanson (2018) AL40-45.
33
oneGPmtwoIPNanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
34
oneGPmtwoIPNretroabsentno1largelargeIP contralateral, VTA and unspecified (v. small)CTB (retrograde)maleSwanson, L.W.Lima, L.B. et al. (2017) J. Comp. Neurol. 525:2411-2442.https://pubmed.ncbi.nlm.nih.gov/28340505/Paxinos & Watson (2007)Injections too large to use positive results; useful for negative evidence ("absent" Connection Reports; see pp. 2420-2425 & Fig. 8). For injection sites see Fig. 7a-c (different injection sites not distinguished in textual description); compare with Swanson (2018) AL40-45.
35
oneGPmtwoIPNretroabsentno1v.largev.largeIP contralateral, PON, CS (v. small)Fluoro-GoldmaleSwanson, L.W.Jhou, T.C. et al. (2009) J. Comp. Neurol. 513:566-596.https://pmc.ncbi.nlm.nih.gov/articles/PMC3116663/Paxinos & Watson (1998)Injection too large to use positive results; useful for negative evidence ("absent" Connection Reports; see Table 1-08031). For injection site see Fig. 6-08031; compare with Swanson (2018) AL40-45.
36
oneGPmoneCLIanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
37
oneGPmtwoCLIanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
38
oneGPmoneCSanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
39
oneGPmoneCSretroabsentno1small-medmediumAT, v. small: DR, PAGvm, IVWGA-apoHRP-GoldmaleSwanson, L.W.Marcinkiewicz, M. et al. (1989) J. Comp. Neurol. 289:11-35.https://pubmed.ncbi.nlm.nih.gov/2478595/Author(s) naming schemaSee p. 16, Table 1, & Fig. 24. For injection site see p. 31 & Figs. 1, 25(1.7); compare with Swanson (2018) AL44.
40
oneGPmtwoCSanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
41
oneGPmtwoCSretroabsentno1small-medmediumAT, v. small: DR, PAGvm, IVWGA-apoHRP-GoldmaleSwanson, L.W.Marcinkiewicz, M. et al. (1989) J. Comp. Neurol. 289:11-35.https://pubmed.ncbi.nlm.nih.gov/2478595/Author(s) naming schemaSee p. 16 & Table 1. For injection site see p. 31 & Figs. 1, 25(1.7); compare with Swanson (2018) AL44.
42
oneGPmoneDRanteroweakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3f,g; compare with Swanson (2018) AL38, 39.
43
oneGPmoneDRretroabsentno1small-medsmall-medDR contralateralCTB (retrograde)unreportedSwanson, L.W.Peyron, C. et al. (1998) Neuroscience 82:443-468.https://pubmed.ncbi.nlm.nih.gov/9466453/Author(s) naming schemaSee Table 1 & Figs. 2-6. Injections are bilateral so only negative results can be used for "absent" Connection Reports. For injection sites see Fig. 1; the one primarily unilateral injection site (Fig. 1E) also spreads significantly to involve PAGvm and PAGvl, so is not useful.
44
oneGPmtwoDRanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3f,g; compare with Swanson (2018) AL38, 39.
45
oneGPmtwoDRretroabsentno1small-medsmall-medDR contralateralCTB (retrograde)unreportedSwanson, L.W.Peyron, C. et al. (1998) Neuroscience 82:443-468.https://pubmed.ncbi.nlm.nih.gov/9466453/Author(s) naming schemaSee Table 1 & Figs. 2-6. Injections are bilateral so only negative results can be used for "absent" Connection Reports. For injection sites see Fig. 1; the one primarily unilateral injection site (Fig. 1E) also spreads significantly to involve PAGvm and PAGvl, so is not useful.
46
oneGPmoneSNcanterov.weakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4i; compare with Swanson (2018) AL47.
47
oneGPmoneSNcretrounclearno1mediummed-largeSNrWGA-HRPmaleSwanson, L.W.Gerfen, C.R. et al. (1982) J. Comp. Neurol. 207:283-303.https://pubmed.ncbi.nlm.nih.gov/7107988/Author(s) naming schemaSee p. 288 & Fig. 2C; compare with Swanson (2018) AL26. Injection too large to use positive data; useful for "absent" connection reports.
48
oneGPmoneSNcanterov.weakno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
49
oneGPmtwoSNcanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4i; compare with Swanson (2018) AL47.
50
oneGPmtwoSNcanteroabsentno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
51
oneGPmtwoSNcretroabsentno1mediummed-largeSNrWGA-HRPmaleSwanson, L.W.Gerfen, C.R. et al. (1982) J. Comp. Neurol. 207:283-303.https://pubmed.ncbi.nlm.nih.gov/7107988/Author(s) naming schemaSee p. 288 & Fig. 2. Injection too large to use positive data; useful for "absent" connection reports.
52
oneGPmoneSNranteromoderateyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4i; compare with Swanson (2018) AL47.
53
oneGPmoneSNrretrounclearno1med-largemediumSNcWGA-HRPmaleSwanson, L.W.Gerfen, C.R. et al. (1982) J. Comp. Neurol. 207:283-303.https://pubmed.ncbi.nlm.nih.gov/7107988/Author(s) naming schemaSee p. 288 & Fig. 2C; compare with Swanson (2018) AL26. Injection too large to use positive data; useful for "absent" connection reports.
54
oneGPmoneSNranteroweak-modno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
55
oneGPmtwoSNranteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4i; compare with Swanson (2018) AL47.
56
oneGPmtwoSNranteroabsentno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
57
oneGPmtwoSNrretroabsentno1med-largemediumSNcWGA-HRPmaleSwanson, L.W.Gerfen, C.R. et al. (1982) J. Comp. Neurol. 207:283-303.https://pubmed.ncbi.nlm.nih.gov/7107988/Author(s) naming schemaSee p. 288 & Fig. 2. Injection too large to use positive data; useful for "absent" connection reports.
58
oneGPmoneVTAanterov.weakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3e,f; compare with Swanson (2018) AL34, 38.
59
oneGPmoneVTAretroabsentno1small-mednoHRPfemaleSwanson, L.W.Phillipson, O.T. (1979) J. Comp. Neurol. 187:117-144.https://pubmed.ncbi.nlm.nih.gov/489776/Author(s) naming schemaFor CNU see p. 125 & Figs. 3-16, 4-16, 5-16. For injection site see Fig. 2-16; compare with Swanson (2018) AL37. Injection 11 not used because it apparently spread to include RN & IF; see p. 132 & Fig. 2-11—compare with Swanson (2018) AL39.
60
oneGPmoneVTAretrov.weakno1largesmallIF, IPNFluoro-goldmaleSwanson, L.W.Geisler, S. & Zahm, D.S. (2005) J. Comp. Neurol. 490:270-294.https://pubmed.ncbi.nlm.nih.gov/16082674/Author(s) naming schemaSee Table 1, Fig. 3E,F; compare with Swanson (2018) AL26-23. For injection site see pp. 273-274 and Figs. 1, 2, & 3A; compare with Swanson (2018) AL36-40.
61
oneGPmoneVTAanterov.weakno1smallv.smallSI (possibly)PHALmaleSwanson, L.W.Luiten, P.G. et al. (1987) Brain Res. 413:229-250.https://pubmed.ncbi.nlm.nih.gov/3300852/Author(s) naming schemaSee p. 237 (Experiment 29) & Fig. 4G; compare with Swanson (2018) AL36.
62
oneGPmoneVTAanterov.weakno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4A-D; compare with Swanson (2018) AL36-39. Injection sites (numerous) not described.
63
oneGPmtwoVTAanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3e,f; compare with Swanson (2018) AL34, 38.
64
oneGPmtwoVTAanteroabsentno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4A-D; compare with Swanson (2018) AL36-39. Injection sites (numerous) not described.
65
oneGPmtwoVTAanteroabsentno1smallv.smallSI (possibly)PHALmaleSwanson, L.W.Luiten, P.G. et al. (1987) Brain Res. 413:229-250.https://pubmed.ncbi.nlm.nih.gov/3300852/Author(s) naming schemaSee p. 237 (Experiment 29) & Fig. 4G; compare with Swanson (2018) AL36.
66
oneGPmtwoVTAretroabsentno1largesmallIF, IPNFluoro-goldmaleSwanson, L.W.Geisler, S. & Zahm, D.S. (2005) J. Comp. Neurol. 490:270-294.https://pubmed.ncbi.nlm.nih.gov/16082674/Author(s) naming schemaSee Table 1, Fig. 3E,F; compare with Swanson (2018) AL26-23. For injection site see pp. 273-274 and Figs. 1, 2, & 3A; compare with Swanson (2018) AL36-40.
67
oneGPmtwoVTAretroabsentno1small-mednoHRPfemaleSwanson, L.W.Phillipson, O.T. (1979) J. Comp. Neurol. 187:117-144.https://pubmed.ncbi.nlm.nih.gov/489776/Author(s) naming schemaFor CNU see p. 125 & Figs. 3-16, 4-16, 5-16. For injection site see Fig. 2-16; compare with Swanson (2018) AL37. Injection 11 not used because it apparently spread to include RN & IF; see p. 132 & Fig. 2-11—compare with Swanson (2018) AL39.
68
oneGPmoneRNanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
69
oneGPmoneRNretroabsentno1smallnoMicrobeads (red)maleSwanson, L.W.Bernays, R.L. et al. (1988) Neuroscience 26:601-619.https://pubmed.ncbi.nlm.nih.gov/3173690/Author(s) naming schemaSee pp. 602-604, Table 1, & Fig. 1. Table 1 shows confirmatory results with larger WGA-HRP injections, with the exceptions noted on p. 604.
70
oneGPmtwoRNanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
71
oneGPmtwoRNretroabsentno1smallnoMicrobeads (red)maleSwanson, L.W.Bernays, R.L. et al. (1988) Neuroscience 26:601-619.https://pubmed.ncbi.nlm.nih.gov/3173690/Author(s) naming schemaSee pp. 602-604, Table 1, & Fig. 1. Table 1 shows confirmatory results with larger WGA-HRP injections, with the exceptions noted on p. 604.
72
oneGPmoneATanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
73
oneGPmoneATretroabsentno1mediummediumCS, v. small: DR, PAGvm, IVWGA-apoHRP-GoldmaleSwanson, L.W.Marcinkiewicz, M. et al. (1989) J. Comp. Neurol. 289:11-35.https://pubmed.ncbi.nlm.nih.gov/2478595/Author(s) naming schemaSee p. 16, Table 1, & Fig. 24. For injection site see p. 31 & Figs. 1, 25(1.7); compare with Swanson (2018) AL44. Injection too large to use positive data; useful for "absent" Connection Reports.
74
oneGPmtwoATanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
75
oneGPmtwoATretroabsentno1mediummediumCS, v. small: DR, PAGvm, IVWGA-apoHRP-GoldmaleSwanson, L.W.Marcinkiewicz, M. et al. (1989) J. Comp. Neurol. 289:11-35.https://pubmed.ncbi.nlm.nih.gov/2478595/Author(s) naming schemaSee p. 16, Table 1, & Fig. 24. For injection site see p. 31 & Figs. 1, 25(1.7); compare with Swanson (2018) AL44. Injection too large to use positive data; useful for "absent" Connection Reports.
76
oneGPmoneMRNmanteroweakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3e-g; compare with Swanson (2018) AL34-39.
77
oneGPmoneMRNmretroweakno1mediumv.smallunclearHRPfemaleSwanson, L.W.Shammah-Lagnado, S.J. et al. (1983) Neuroscience 9:391-409.https://pubmed.ncbi.nlm.nih.gov/6877601/Author(s) naming schemaSee pp. 392-393, Table 1, & Fig. 2F; compare with Swanson (2018) AL28. For injection sites see Fig. 1; compare with Swanson (2018) AL37-41.
78
oneGPmoneMRNmretroweakno1small-mednoFluoro-GoldmaleSwanson, L.W.Jhou, T.C. et al. (2009) J. Comp. Neurol. 513:566-596.https://pmc.ncbi.nlm.nih.gov/articles/PMC3116663/Paxinos & Watson (1998)See Table 1-06164; for injection site see Fig. 6-06164 & compare with Swanson (2018) AL40-41.
79
oneGPmoneMRNmanteroweakno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
80
oneGPmtwoMRNmanterov.weakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3e-g; compare with Swanson (2018) AL34-39.
81
oneGPmtwoMRNmanteroabsentno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4B-F; compare with Swanson (2018) AL36-40. Injection sites (numerous) not described.
82
oneGPmtwoMRNmretroabsentno1small-mednoFluoro-GoldmaleSwanson, L.W.Jhou, T.C. et al. (2009) J. Comp. Neurol. 513:566-596.https://pmc.ncbi.nlm.nih.gov/articles/PMC3116663/Paxinos & Watson (1998)See Table 1-06164; for injection site see Fig. 6-06164 & compare with Swanson (2018) AL40-41.
83
oneGPmtwoMRNmretrov.weakno1mediumv.smallunclearHRPfemaleSwanson, L.W.Shammah-Lagnado, S.J. et al. (1983) Neuroscience 9:391-409.https://pubmed.ncbi.nlm.nih.gov/6877601/Author(s) naming schemaSee pp. 392-393, Table 1, & Fig. 2F; compare with Swanson (2018) AL28. For injection sites see Fig. 1; compare with Swanson (2018) AL37-41.
84
oneGPmoneMRNpanteroweak-modyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4h; compare with Swanson (2018) AL44.
85
oneGPmoneMRNpretroweakno1med-largev.smallMRNm, PPN, CUNWGA-HRPmaleSwanson, L.W.Steininger, T.L. et al. (1992) J. Comp. Neurol. 321:515-543.https://pubmed.ncbi.nlm.nih.gov/1380518/Author(s) naming schemaSee pp. 527-531 (their MEA), Table 3 (Experiment R192), and Fig. 8D; compare with Swanson (2018) AL28. For injection site see Fig. 3-R192 (compare with Swanson, 2018, AL40-46) and Fig. 9A (compare with Swanson, 2018, AL45).
86
oneGPmoneMRNpanterov.weakno1unreportedunreportedunreportedWGA-HRPunreportedSwanson, L.W.Rye, D.B. et al. (1987) J. Comp. Neurol. 259:483-528.https://pubmed.ncbi.nlm.nih.gov/2885347/Author(s) naming schemaSee p. 514.
87
oneGPmtwoMRNpanteroweakyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 4h; compare with Swanson (2018) AL44.
88
oneGPmtwoMRNpanteroabsentno1unreportedunreportedunreportedWGA-HRPunreportedSwanson, L.W.Rye, D.B. et al. (1987) J. Comp. Neurol. 259:483-528.https://pubmed.ncbi.nlm.nih.gov/2885347/Author(s) naming schemaSee p. 514.
89
oneGPmtwoMRNpretrov.weakno1med-largev.smallMRNm, PPN, CUNWGA-HRPmaleSwanson, L.W.Steininger, T.L. et al. (1992) J. Comp. Neurol. 321:515-543.https://pubmed.ncbi.nlm.nih.gov/1380518/Author(s) naming schemaSee pp. 527-531 (their MEA), Table 3 (Experiment R192), and Fig. 8D; compare with Swanson (2018) AL28. For injection site see Fig. 3-R192 (compare with Swanson, 2018, AL40-46) and Fig. 9A (compare with Swanson, 2018, AL45).
90
oneGPmoneRRretroweakyes11 20201small-medv.smallunclearFluoro-GoldmaleSwanson, L.W.Zahm, D.S. et al. (2011) J. Comp. Neurol. 519:3159-3188.https://pmc.ncbi.nlm.nih.gov/articles/PMC3174784/Author(s) naming schemaSee pp. 3164-3171 & Table 3. For 3 injection sites see Fig. 1A-C & compare with Swanson (2018) AL40.
91
oneGPmoneRRanterov.weakno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4E,F; compare with Swanson (2018) AL40. Injection sites (numerous) not described.
92
oneGPmtwoRRretrounclearyes11 20201small-medv.smallunclearFluoro-GoldmaleSwanson, L.W.Zahm, D.S. et al. (2011) J. Comp. Neurol. 519:3159-3188.https://pmc.ncbi.nlm.nih.gov/articles/PMC3174784/Author(s) naming schemaSee pp. 3164-3171 & Table 3. For 3 injection sites see Fig. 1A-C & compare with Swanson (2018) AL40.
93
oneGPmtwoRRanteroabsentno1small-mednoprobably nonePHALmaleSwanson, L.W.Hay-Schmidt, A. & Mikkelsen, J.D. (1992) Brain Res. 576:343-347.https://pubmed.ncbi.nlm.nih.gov/1381264/Author(s) naming schemaSee p. 344 & Fig. 4E,F; compare with Swanson (2018) AL40. Injection sites (numerous) not described.
94
oneGPmonePRCanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
95
oneGPmonePRCretroabsentno1v.largev.smallPAGrn, PAGmCTB (retrograde)maleSwanson, L.W.Canteras, N.S. & Goto, M. (1999) J. Comp. Neurol. 408:23-45.https://pubmed.ncbi.nlm.nih.gov/10331578/Swanson BM1 (1992)See p. 27 & Fig. 3; compare with Swanson (2018).
96
oneGPmtwoPRCanteroabsentyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Figs. 3, 4.
97
oneGPmtwoPRCretroabsentno1v.largev.smallPAGrn, PAGmCTB (retrograde)maleSwanson, L.W.Canteras, N.S. & Goto, M. (1999) J. Comp. Neurol. 408:23-45.https://pubmed.ncbi.nlm.nih.gov/10331578/Swanson BM1 (1992)See p. 27 & Fig. 3; compare with Swanson (2018).
98
oneGPmoneCOManteroabsentyes11 20201smallv.smallSI (possibly)PHALmaleSwanson, L.W.Luiten, P.G. et al. (1987) Brain Res. 413:229-250.https://pubmed.ncbi.nlm.nih.gov/3300852/Author(s) naming schemaSee p. 237 (Experiment 29) & Fig. 4G; compare with Swanson (2018) AL36.
99
oneGPmtwoCOManteroabsentyes11 20201smallv.smallSI (possibly)PHALmaleSwanson, L.W.Luiten, P.G. et al. (1987) Brain Res. 413:229-250.https://pubmed.ncbi.nlm.nih.gov/3300852/Author(s) naming schemaSee p. 237 (Experiment 29) & Fig. 4G; compare with Swanson (2018) AL36.
100
oneGPmonePAGrnanteroweak-modyes11 20201mediumnoPHALmaleSwanson, L.W.Takada, M. et al. (1994) J. Comp. Neurol. 342:409-429.https://pubmed.ncbi.nlm.nih.gov/8021342/Author(s) naming schemaSee pp. 411-414 & Fig. 3e; compare with Swanson (2018) AL34.